|
Concord Biotech Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
16148.56 Cr.
|
P/BV
|
10.15
|
Book Value (Rs.)
|
152.02
|
|
52 Week High/Low (Rs.)
|
2664/1327
|
FV/ML
|
1/1
|
P/E(X)
|
52.41
|
|
Bookclosure
|
29/06/2024
|
EPS (Rs.)
|
29.45
|
Div Yield (%)
|
0.57
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 29.45 | 22.95 | 16.72 |
| Diluted EPS (Rs.) | 29.45 | 22.95 | 16.72 |
| Cash EPS (Rs.) | 34.25 | 27.93 | 240.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 145.93 | 123.31 | 1159.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 145.93 | 123.31 | 1159.99 |
| Revenue From Operations / Share (Rs.) | 97.21 | 81.55 | 749.62 |
| PBDIT / Share (Rs.) | 44.48 | 36.19 | 311.96 |
| PBIT / Share (Rs.) | 39.36 | 31.02 | 259.33 |
| PBT / Share (Rs.) | 39.11 | 30.59 | 253.57 |
| Net Profit / Share (Rs.) | 29.13 | 22.76 | 187.76 |
| NP After MI And SOA / Share (Rs.) | 29.45 | 22.95 | 183.93 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 45.75 | 44.37 | 41.61 |
| PBIT Margin (%) | 40.48 | 38.04 | 34.59 |
| PBT Margin (%) | 40.23 | 37.51 | 33.82 |
| Net Profit Margin (%) | 29.96 | 27.91 | 25.04 |
| NP After MI And SOA Margin (%) | 30.29 | 28.14 | 24.53 |
| Return on Networth / Equity (%) | 20.18 | 18.61 | 15.85 |
| Return on Capital Employeed (%) | 26.41 | 24.54 | 21.30 |
| Return On Assets (%) | 18.11 | 15.85 | 13.32 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 |
| Total Debt / Equity (X) | 0.00 | 0.02 | 0.05 |
| Asset Turnover Ratio (%) | 0.63 | 0.60 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 6.30 | 3.79 | 4.08 |
| Quick Ratio (X) | 4.84 | 2.69 | 2.82 |
| Inventory Turnover Ratio (X) | 0.87 | 0.82 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 23.19 | 22.31 | 40.31 |
| Dividend Payout Ratio (CP) (%) | 19.75 | 18.21 | 31.34 |
| Earning Retention Ratio (%) | 76.81 | 77.69 | 59.69 |
| Cash Earning Retention Ratio (%) | 80.25 | 81.79 | 68.66 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 182.35 | 83.94 | 54.11 |
| Interest Coverage Ratio (Post Tax) (%) | 120.41 | 53.80 | 33.56 |
| | | | |
| VALUATION RATIOS | | | |
| | | | |
| Enterprise Value (Cr.) | 15881.24 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 15.62 | 0.00 | 0.00 |
| EV / EBITDA (X) | 34.13 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 15.66 | 0.00 | 0.00 |
| Retention Ratios (%) | 76.80 | 77.68 | 59.68 |
| Price / BV (X) | 10.43 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 15.66 | 0.00 | 0.00 |
| EarningsYield | 0.01 | 0.00 | 0.00 |
